Guohui Xue

439 citations
27 papers · 294 indexed · h-index 9
Topics
Advanced biosensing and bioanalysis techniques (9 papers)RNA Interference and Gene Delivery (8 papers)COVID-19 Clinical Research Studies (4 papers)
Partner nations
ChinaUnited Kingdom

In The Last Decade

Guohui Xue

25 papers receiving 293 citations

Peers

Guohui Xue
Comparison fields: 5 of 77
  • Molecular Biology 96
  • Infectious Diseases 76
  • Immunology 66
  • Epidemiology 61
  • Oncology 41
Replace Jeroen Slaats with:
Jeroen Slaats Netherlands
Rainer Knoll Germany
Marc Diedisheim France
Andrzej K. Ciechanowicz Poland
Xi Zhao China
Hannelore P. Van Eeckhoutte Belgium
Natalie Vaninov United States
Amal F. Alshammary Saudi Arabia
Rosa Lavieri Italy
Yanjiao Lu China
Guohui Xue relative to Jeroen Slaats Netherlands Jeroen Slaats's profile →
Citations per field
00.5×3.3×
Jeroen Slaats · 1×
Citations per year

Countries citing papers authored by Guohui Xue

Since Specialization
Citations

This map shows the geographic impact of Guohui Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohui Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohui Xue more than expected).

Fields of papers citing papers by Guohui Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guohui Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohui Xue. The network helps show where Guohui Xue may publish in the future.

Co-authorship network of co-authors of Guohui Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Guohui Xue. A scholar is included among the top collaborators of Guohui Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guohui Xue. Guohui Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 4
4 1
5 6
6 6
7 8
8 0
9 1
10 14
11 5
12 4
13 7
14 6
15 7
16 4
17 6
18 38
19
Clinical value of anal swab positive in COVID-19 patients
2
20 15

About Guohui Xue

Guohui Xue is a scholar working on Immunology, Infectious Diseases and Otorhinolaryngology, having authored 27 papers that have together received 294 indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (9 papers), RNA Interference and Gene Delivery (8 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Infectious Diseases (76 citations), Immunology (66 citations) and Epidemiology (61 citations). Guohui Xue has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Junming Li, Lin Hua, Nanjin Zhou, Jie Xiang, Dan Xie, Yan Xiong, Zhìqiáng Wú, Yunfeng Shen, Xiaoyang Lai and Fangfang Li. Their work appears in journals such as Advanced Functional Materials, Analytical Chemistry and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026